QYUNS-B(02509),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02509 QYUNS-B

Not Yet Opened 01-21 16:08:54

22.480

+0.820

+3.79%

High22.740	Low21.640	Vol186.20K
Open22.740	D1 Closing21.660	Amplitude5.08%
Mkt Cap5.06B	Tradable Cap5.06B	Total Shares225.00M
T/O4.13M	T/O Rate0.08%	Tradable Shares225.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":22.48,"timestamp":1768982934287,"preClose":21.66,"halted":0,"volume":186200,"delay":0,"changeRate":0.0378578024007387,"floatShares":225000000,"shares":225000000,"eps":-1.713333651114195,"marketStatus":"Not Yet Opened","change":0.82,"latestTime":"01-21 16:08:54","open":22.74,"high":22.74,"low":21.64,"amount":4130424,"amplitude":0.050785,"askPrice":22.48,"askSize":3000,"bidPrice":22.3,"bidSize":4800,"shortable":3,"etf":0,"ttmEps":-0.9675475173951689,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769045400000},"marketStatusCode":0,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":21.66,"openAndCloseTimeList":[[1768959000000,1768968000000],[1768971600000,1768982400000]],"volumeRatio":0.9240694783120149,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/wiki","defaultTab":"wiki","newsList":[{"id":"1109730670","title":"QYUNS-B (02509) Repurchases 44,000 Shares for HK$988,800 on January 21","url":"https://stock-news.laohu8.com/highlight/detail?id=1109730670","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109730670?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:54","pubTimestamp":1769000053,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on January 21, 2026, the company repurchased 44,000 shares at a cost of HK$988,800. The repurchase price ranged from HK$22.08 to HK$22.50 per share.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1160614428","title":"CICC Initiates Coverage on QYUNS-B (02509) with Outperform Rating, Sets Target Price at HK$33.00","url":"https://stock-news.laohu8.com/highlight/detail?id=1160614428","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160614428?lang=en_us&edition=fundamental","pubTime":"2026-01-21 10:56","pubTimestamp":1768964187,"startTime":"0","endTime":"0","summary":"CICC has released a research report forecasting that QYUNS-B (02509) will achieve EPS of 1.61 yuan, 0.88 yuan, and 0.55 yuan for 2025 to 2027, respectively. The firm initiated coverage with an...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1142947249","title":"QYUNS-B (02509) Repurchases 53,000 Shares for HK$1.18 Million on January 19","url":"https://stock-news.laohu8.com/highlight/detail?id=1142947249","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142947249?lang=en_us&edition=fundamental","pubTime":"2026-01-19 20:44","pubTimestamp":1768826666,"startTime":"0","endTime":"0","summary":"On January 19, 2026, QYUNS-B (02509) announced a share repurchase, spending HK$1.18 million to buy back 53,000 shares.\nThe repurchase price ranged from HK$21.98 to HK$23.08 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1178108312","title":"Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1178108312","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178108312?lang=en_us&edition=fundamental","pubTime":"2026-01-19 20:41","pubTimestamp":1768826495,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"1187095824","title":"Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Treasury Share Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1187095824","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187095824?lang=en_us&edition=fundamental","pubTime":"2026-01-16 21:22","pubTimestamp":1768569753,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 16 January 2026. The company repurchased 45,000 ordinary shares, resulting in an adjusted total of 225,286,000 issued shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"1120104602","title":"QYUNS-B Spent HK$682,800 on January 15 to Repurchase 29,600 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1120104602","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120104602?lang=en_us&edition=fundamental","pubTime":"2026-01-16 08:30","pubTimestamp":1768523426,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on January 15, 2026, the company repurchased 29,600 shares at a cost of HK$682,800, with a repurchase price per share ranging from HK$23.02 to HK$23.18.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1143628481","title":"QYUNS-B (02509): QX030N/CLD-423 Completes First Dosing in Phase I Trial; Caldera Therapeutics Raises $112.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=1143628481","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143628481?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:38","pubTimestamp":1768401499,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that the Phase I clinical trial of its bispecific antibody, QX030N/CLD-423, which targets the clinically validated IL-23p19 and TL1A pathways, has successfully administered...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1192925609","title":"QYUNS-B (02509) Repurchases 27,200 Shares for HK$618,000 on January 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1192925609","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192925609?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:14","pubTimestamp":1768400051,"startTime":"0","endTime":"0","summary":"On January 14, 2026, the company announced it had repurchased 27,200 of its own shares at a total cost of approximately HK$618,000.\nThe repurchase price per share ranged between HK$22.54 and HK$22.88.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1105363546","title":"QYUNS-B (02509) Repurchases 79,600 Shares for HK$1.75 Million on January 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1105363546","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105363546?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:52","pubTimestamp":1768225953,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on January 12, 2026, the company repurchased 79,600 shares at a cost of HK$1.75 million. For more significant Hong Kong stock information and overseas wealth management...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2601809342","title":"Qyuns Therapeutics Repurchases HK$31.16 Million in Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601809342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601809342?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:09","pubTimestamp":1767794997,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co. Ltd. has announced a repurchase of a total of 1,575,800 ordinary shares on The Stock Exchange of Hong Kong Limited, with an aggregate amount involved of approximately HK$31.16 million . The repurchased shares represent about 0.69% of the company’s existing total issued shares as of the announcement date. The company stated that the buyback was conducted under a repurchase mandate to reinforce market confidence and enhance investment value.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 07, 2026, and is solely responsible for the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL2fxQ7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1140249954","title":"QYUNS-B (02509) Repurchases 38,800 Shares for HK$778,400 on January 6","url":"https://stock-news.laohu8.com/highlight/detail?id=1140249954","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140249954?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:50","pubTimestamp":1767711014,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on January 6, 2026, the company repurchased 38,800 shares at a cost of HK$778,400. The repurchase price ranged from HK$19.96 to HK$20.10 per share.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2601005865","title":"Qyuns Therapeutics Co., Ltd. (HKG:2509) About To Shift From Loss To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2601005865","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601005865?lang=en_us&edition=fundamental","pubTime":"2026-01-06 08:50","pubTimestamp":1767660635,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. ( HKG:2509 ) is possibly approaching a major achievement in its business, so we would like...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/qyuns-therapeutics-co-ltd-hkg2509-about-to-shift-from-loss-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/qyuns-therapeutics-co-ltd-hkg2509-about-to-shift-from-loss-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","02509","BK4539","BK1161","LENZ","BK4007"],"gpt_icon":0},{"id":"1110982559","title":"QYUNS-B (02509) Repurchases 25,000 Shares for HK$476,900 on January 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1110982559","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110982559?lang=en_us&edition=fundamental","pubTime":"2026-01-02 21:50","pubTimestamp":1767361814,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on January 2, 2025, the company repurchased 25,000 of its own shares at a total cost of HK$476,900. The repurchase price per share ranged from HK$18.75 to HK$19.20.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1174407833","title":"Zhixiang Hong Kong Stock Repurchase Statistics | January 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1174407833","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174407833?lang=en_us&edition=fundamental","pubTime":"2026-01-01 09:13","pubTimestamp":1767230019,"startTime":"0","endTime":"0","summary":"A total of 58 companies conducted share buybacks on December 31, 2025. Among them, TENCENT (00700) executed the largest buyback by value, repurchasing 1.061 million shares for HK$635 million. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0856984785.SGD","LU0823041008.USD","LU1226288097.SGD","SG9999015952.SGD","LU0605514214.HKD","LU0269904917.USD","LU0828237510.HKD","LU0348735423.USD","LU1769817179.HKD","BK1542","BK1105","LU2106854487.HKD","LU0181495838.USD","LU2279701549.SGD","LU1720050803.USD","SG9999001846.SGD","BK1109","IE00BZ08YT58.USD","LU0320764755.SGD","LU0880133367.SGD","IE00B29SXG58.USD","LU1242518857.USD","BK1531","SG9999003461.SGD","LU1810669033.SGD","06609","LU0979878070.USD","LU1023057109.AUD","BK1583","IE0034224299.USD","LU0348766576.USD","LU1152091168.USD","LU0541502299.USD","SG9999007991.SGD","LU1242518931.SGD","LU1102505762.USD","BK1161","LU0048597586.USD","LU0096374516.USD","LU0683595622.HKD","LU2097828714.EUR","LU0502904849.HKD","BK1587","LU2265009873.SGD","LU0823426308.USD","LU0359202008.SGD","LU2476274308.USD","LU0823413660.USD","01516","LU1868837722.USD","LU0463099449.HKD","BK1506","BK1142","BK1515","02678","LU1770036033.HKD","LU2498475776.HKD","LU0320764599.SGD","LU1044874839.SGD","LU0228367735.SGD","BK1144","LU1808992512.USD","LU0543330566.HKD","LU2237443465.HKD","SGXZ99366536.SGD","LU0823038988.USD","LU0348784397.USD","LU1725190679.HKD","06100","BK1128","LU0449515922.USD","01897","LU0106259558.USD","LU0054450605.USD","SG9999006597.SGD","LU0370786039.SGD","LU0175139822.USD","LU0865486749.SGD","SGXZ81514606.USD","LU0823413587.USD","LU0261950983.USD","09857","LU1880383440.USD","LU0608807946.USD","LU0348805143.USD","LU0738912210.USD","01995","LU1733274390.USD","BK1104","LU2097828805.USD","IE0031814852.USD","LU0651947912.USD","LU0067412154.USD","LU0188438112.USD","LU2226246903.HKD","LU2237443549.SGD","LU0173614495.USD","BK1095","LU0293314216.USD","LU0132412106.USD","BK1131","LU2399975544.HKD","LU2177674079.SGD","LU1770034418.SGD","BK1518","BK1167","SGXZ90724238.SGD","LU2460026573.USD","00700","HK0000165453.HKD","IE00B97KM107.HKD","LU1481107354.HKD","LU0061477393.USD","LU1048596156.SGD","LU1688375341.USD","BK1521","02142","IE0032834883.USD","HXXD.SI","09896","LU1048588211.SGD","LU1226287529.USD","LU1439103000.SGD","LU0577902371.SGD","06098","GB00BDT5M118.USD","LU0531970944.HKD","LU1655091459.SGD","SG9999001903.USD","LU0823040885.USD","LU0051755006.USD","LU0588545730.USD","01588","LU0417516902.SGD","LU1282651121.HKD","00345","IE00B5MMRT66.SGD","LU2152927971.USD","BK1566","03798","LU0588545904.SGD","09878","HK0000320223.HKD","LU1675838814.USD","BK1229","LU1102505929.USD","LU1956131251.USD","LU0862451837.USD","LU2237443978.SGD","LU0648948544.HKD","02621","BK1195","LU0128522157.USD","SG9999001226.SGD","02391","BK1100","LU2087589342.USD","LU1188198961.HKD","LU0047713382.USD","LU1981816686.USD","LU0345769128.USD","BK1249","LU0314109678.HKD","LU0823397103.USD","IE0003795394.USD","LU0611395673.USD","LU2133065610.SGD","01458","LU1226287792.SGD","09922","LU0642271901.SGD","LU2362541513.USD","LU0072462343.USD","LU1105468828.SGD","LU1196710351.USD","LU1226287875.USD","02652","LU0254981946.USD","LU0320764243.SGD","LU0455707207.USD","SG9999000459.SGD","LU2449936058.SGD","IE00B0169L03.USD","LU0737861699.HKD","LU2125910500.SGD","LU1568876335.HKD","LU1785774172.SGD","LU0700851271.USD","LU0244354667.USD","LU0608807433.USD","LU1804176565.USD","LU0348816934.USD","LU1814569148.SGD","LU1813983027.USD","LU0307460666.USD","LU0070217475.USD","IE0009570106.USD","SG9999018857.SGD","BK1500","LU0211331839.USD","LU1807302812.USD","IE00B8HQ1Z84.USD","SG9999004220.SGD","SG9999014898.SGD","LU1323998911.USD","LU2237443382.USD","LU0011963245.USD","LU0516422440.USD","LU1235295612.USD","LU0149534421.HKD","BK1155","LU0873338254.USD","SG9999006514.SGD","LU1831875114.USD","LU0588546209.SGD","LU0821914370.USD","LU1051769294.HKD","BK1613","LU1366334578.USD","IE00BZ08YR35.GBP","LU0251144936.SGD","01868","IE0003851619.USD","SG9999001069.SGD","BK1608","BK1526","BK1619","LU2023250504.SGD","LU0650527681.SGD","LU0541501648.USD","BK1183","HK0000320264.USD","BK1246","LU0315178854.USD","LU1152091754.HKD","LU0106252389.USD","LU0203345920.USD","LU2237443895.HKD","BK1523","LU0675040207.SGD","LU0043850808.USD","LU0384037296.USD","LU0823397285.USD","LU1008478684.HKD","02121","LU0499858438.USD","LU0577902298.EUR","LU2476274720.SGD","LU0192582467.USD","BK1160","LU0054237671.USD","LU0164880469.USD","LU0117841782.USD","SGXZ51526630.SGD","LU0456842615.SGD","LU1504937902.USD","LU1282649141.HKD","LU0577902454.USD","LU0797268264.HKD","SG9999014674.SGD","LU0169518387.USD","LU0348814723.USD","LU1282649810.SGD","BK1589","LU0878004406.USD","06868","BK1215","02886","LU0196878994.USD","IE00BQXX3F31.USD","LU1951186391.HKD","LU0862451753.SGD","BK1237","LU0540923850.HKD","LU1515016050.SGD","02038","IE0032431581.USD","06608","09669","LU0396098781.USD","IE00B0JY6N72.USD","LU2247934214.USD","IE0003895053.USD","LU0348827113.USD","HK0000252160.HKD","LU3063872942.SGD","HK0000306685.HKD","03650","LU0211977185.USD","LU0588545490.SGD","LU0828237940.HKD","LU1282649067.USD","LU1868837565.USD","BK1193","SG9999018865.SGD","LU0259732245.USD","00909","LU0594300419.USD","SG9999001093.SGD","LU0737861772.HKD","LU0235996351.USD","LU0326948709.USD","IE00B543WZ88.USD","BK1604","02517","LU1568876251.USD","BK1258","02869","LU0516423091.SGD","LU0516423174.USD","LU1960683339.HKD","LU0786609619.USD","01024","LU0577902611.USD","BK1590","01600","LU0287142896.SGD","SG9999017495.SGD","LU2097828631.EUR","LU0048388663.USD","BK1117","09886","LU0831103253.SGD","XIACY","LU0784639295.USD","LU0143863784.USD","LU0819123356.HKD","LU1642822792.SGD","SG9999000327.SGD","LU2045819591.USD","LU2251237306.USD","LU1734074674.USD","06831","LU0072913022.USD","06078","IE00B031HW06.USD","LU1974910355.USD","01274","LU0633140727.USD","LU0140636845.USD","SGXZ31699556.SGD","LU0607220059.USD","LU0326950275.SGD","LU1439102457.SGD","LU1224444064.USD","LU2237443622.USD","BK1116","LU0359201612.USD","LU0543330483.HKD","LU0561508036.HKD","LU1282651048.USD","LU2293587155.HKD","SG9999015986.USD","LU0516422952.EUR","LU0868486357.SGD","LU1719994722.HKD","LU1196710864.SGD","LU0049112450.USD","LU0261947096.USD","BK1247","LU0985320562.USD","LU0918141705.HKD","BK1618","LU1883866441.USD","LU1328615791.USD","LU0348783233.USD","LU0345775950.USD","LU0708995583.HKD","LU1917777945.USD","BK1502","LU0359201885.HKD","LU0048580855.USD","LU0572940350.SGD","LU1282648689.USD","LU1794554557.SGD","LU0231483743.USD","LU0456827905.SGD","BK1609","LU2251237488.HKD","LU1044876610.USD","LU2778985437.USD","LU1718418525.SGD","LU0163747925.USD","BK1574","LU0052750758.USD","LU2317271919.USD","02299","IE00B0169N27.USD","BK1575","LU0572939691.SGD","LU0327786744.USD","LU0049853897.USD","LU0918141887.USD","IE0001KFT4U8.USD","LU0128522744.USD","LU0143863198.USD","LU0531971595.HKD","IE00B031HY20.USD","LU0871576103.HKD","LU1629966141.USD","BK1586","LU0791591158.USD","81810","LU0708995153.HKD","LU2125910849.SGD","LU0634319403.HKD","LU0228659784.USD","LU0164865239.USD","LU0348825331.USD","LU1051768304.USD","06887","LU0106959298.USD","SG9999001689.USD","LU1226288170.HKD","LU0264606111.USD","LU0449509016.USD","LU0348788117.USD","IE0008368742.USD","LU1226288253.USD","LU2257852520.SGD","LU0882747503.HKD","02509","LU1251922891.USD","LU1196710195.USD","LU1303224171.USD","BK1504","LU0414403682.SGD","LU2008162690.USD","IE00BF5LJ272.USD","00314","01672","LU1224709979.USD","LU0127658192.USD","LU0210533765.USD","LU0456846285.SGD","LU1211504680.USD","LU2462611646.USD","LU0229945570.USD","LU0898667661.SGD","LU2362540622.SGD","BK1233","LU1961090484.USD","SG9999002828.SGD","LU0329678337.USD","BK1591","IE00BPRC5H50.USD","LU0165289439.USD","LU0210526637.USD","LU0164872284.USD","01810","LU0488056044.USD","LU1880383366.USD","02419","LU0577902538.SGD","BK1615","LU1046422090.SGD","LU0441854154.USD","BK1607","81024","IE0008369823.USD","02018","IE00BZ08YS42.EUR","LU0469268626.HKD","BK1132","LU0328353924.USD","LU0509642566.USD","LU0149721374.USD","LU1868838027.USD","LU0828238088.HKD","LU0972618739.USD","LU2097828557.USD","IE00BQXX3C00.GBP","SG9999014880.SGD","LU0499858602.USD","LU0589944569.HKD","BK1209","LU0572944931.SGD","LU0593848301.USD","BK1191","LU2051468812.USD","02598","LU2362541273.HKD","LU0029875118.USD","HTCD.SI","IE00B067MR52.USD","02219","IE00B031J352.USD","LU0210527791.USD","SG9999002463.SGD","LU0084288322.USD","IE00B3M56506.USD","LU0345769631.USD","BK1124","TCHmain","LU0117844026.USD","09959","BK1517","LU1316542783.SGD","LU0080751232.USD","IE00BQXX3D17.EUR","LU0214875030.USD","BK1221","LU1044875133.USD","02586","01651","LU2488822045.USD","LU0823039010.USD","SG9999001051.SGD","HK0000252152.HKD","BK1516","LU0289960550.SGD","02866","LU0329678170.USD","LU0417516571.SGD","SG9999002562.SGD","LU2242644610.SGD","SG9999015945.SGD","HK0000306701.USD","LU0348767384.USD","IE00B8L5B284.USD","09966","IE0008368411.USD","LU1048484197.HKD","HK0000500386.USD","LU0633140560.USD","LU0431992006.USD","BK1585","BK1535","BK1549","LU2097828474.EUR","SG9999015978.USD","LU0501845795.SGD","LU0345776255.USD","LU0672654166.SGD","LU1993786604.SGD","LU0791590937.USD","LU1328277881.USD","LU1366334651.USD","SG9999014906.USD","IE00BGV7N243.SGD","LU0878005551.USD","LU0886674414.USD","LU0417516738.SGD","LU0651946864.USD","SG9999014914.USD","LU0107464264.USD","LU0819121731.USD","LU0516422366.SGD","LU0029874905.USD","SG9999013353.USD","LU0348723411.USD","LU0594300179.USD","BK1610","SG9999000418.SGD","02416","BK1253","LU0039217434.USD","LU0823426480.USD","LU0890818403.SGD","LU0348783662.USD","LU1769817096.USD","08017","BK1508","LU2039709279.SGD","LU1733274473.HKD","LU0203347892.USD"],"gpt_icon":1},{"id":"1131014448","title":"QYUNS-B (02509) Repurchases 160,000 Shares for HK$3.03 Million on December 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1131014448","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131014448?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:40","pubTimestamp":1767188412,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on December 31, 2025, it repurchased 160,000 shares at a total cost of HK$3.03 million.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1127132525","title":"QYUNS-B (02509) Repurchases 92,800 Shares for HK$1.6781 Million on December 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1127132525","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127132525?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:28","pubTimestamp":1767018491,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on December 29, 2025, the company repurchased 92,800 shares at a total cost of HK$1.6781 million.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1145935759","title":"Hong Kong Stocks Movement | QYUNS-B (02509) Rises Over 4% as Bispecific Antibody Drug QX027N Licensed Overseas, Potential Payments Up to $700 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1145935759","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145935759?lang=en_us&edition=fundamental","pubTime":"2025-12-22 10:28","pubTimestamp":1766370485,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) surged over 4%, reaching HK$19.61 by the time of writing, with a trading volume of HK$3.0957 million. The company announced earlier today that on December 19, it entered into a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2593172463","title":"Qyuns Therapeutics Sells QX027N Drug License to LE2025 Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2593172463","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593172463?lang=en_us&edition=fundamental","pubTime":"2025-12-22 09:50","pubTimestamp":1766368237,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  sold the global license to its QX027N drug to Windward Bio Group affiliate LE2025 Therapeutics, according to a Hong Kong bourse filing Monday.The license covers all regions except mainland China, Taiwan, Hong Kong, and Macau.Qyuns sold the license for payments totaling up to $700 million, including an upfront payment, an equity interest of Windward Bio, milestone payments, and royalties on the sales of the drug.QX027N is being studied as a treatment for asthma and atopic dermatitis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","02509","BK4007","BK4139","BK1161","BK4539"],"gpt_icon":0},{"id":"2593859174","title":"BRIEF-Qyuns Therapeutics Enters License & Collaboration Agreement With LE2025 Therapeutics AG","url":"https://stock-news.laohu8.com/highlight/detail?id=2593859174","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593859174?lang=en_us&edition=fundamental","pubTime":"2025-12-22 09:08","pubTimestamp":1766365723,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Enters License & Collaboration Agreement With LE2025 Therapeutics AGDec 22  - Qyuns Therapeutics Co Ltd 2509.HK:ENTERS LICENSE & COLLABORATION AGREEMENT WITH LE2025 THERAPEUTICS AGGROUP TO RECEIVE TOTAL OF UP TO $700 MILLION PAYMENTS, INCLUDING UPFRONT PAYMENT, OTHERSLE2025 GRANTED EXCLUSIVE RIGHTS FOR QX027N DEVELOPMENT GLOBALLY EXCEPT FROM MAINLAND CHINA, OTHERSFurther company coverage: 2509.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XQ00Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1154764518","title":"QYUNS-B (02509) Signs Licensing and Collaboration Agreement with Windward Bio Subsidiary for Development and Commercialization of QX027N","url":"https://stock-news.laohu8.com/highlight/detail?id=1154764518","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154764518?lang=en_us&edition=fundamental","pubTime":"2025-12-22 08:22","pubTimestamp":1766362942,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on December 19, 2025, the company entered into a licensing and collaboration agreement with LE2025 Therapeutics AG (LE2025), a subsidiary of Windward Bio Group AG...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":-0.0201},{"period":"1month","weight":0.1794},{"period":"3month","weight":-0.1072},{"period":"6month","weight":0.206},{"period":"1year","weight":2.0543},{"period":"ytd","weight":0.197}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0304},{"period":"3month","weight":0.0238},{"period":"6month","weight":0.0471},{"period":"1year","weight":0.3222},{"period":"ytd","weight":0.0372}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Qyuns Therapeutics Co Ltd is a China-based company mainly engaged in biopharmaceuticals. The Company is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The Company's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The Company is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The Company's core products include QX002N and QX005N.","exchange":"SEHK","name":"QYUNS-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"QYUNS-B(02509),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest QYUNS-B(02509) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"QYUNS-B,02509,QYUNS-B股票,QYUNS-B股票老虎,QYUNS-B股票老虎国际,QYUNS-B行情,QYUNS-B股票行情,QYUNS-B股价,QYUNS-B股市,QYUNS-B股票价格,QYUNS-B股票交易,QYUNS-B股票购买,QYUNS-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"QYUNS-B(02509),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest QYUNS-B(02509) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}